Infectious disease
Infections clinical trials
Bacterial, viral, and other infections — from common illnesses to emerging threats. We’re tracking 3,968 recruiting studies in this area right now.
By phase
- Not applicable2,549
- Phase 2357
- Phase 4301
- Phase 1287
- Phase 3282
- Phase 1/Phase 2132
- Phase 2/Phase 360
Top conditions
Leading sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)88
- Assistance Publique - Hôpitaux de Paris69
- University of California, San Francisco39
- Johns Hopkins University30
- National Cancer Institute (NCI)28
- Hospices Civils de Lyon27
- Columbia University24
- University of Alabama at Birmingham23
- University of Oxford23
- University of Washington23
Where studies are running
- California233
- Maryland142
- Alabama93
- New York73
- Florida72
- Texas62
- Massachusetts57
- Arizona48
- Pennsylvania43
- Illinois41
Recruiting studies3,968 total
- NCT07683104Recruiting
How trisomy 8 autoinflammatory disease progresses over time
This study follows people who have trisomy 8 (an extra copy of a chromosome) that causes inflammation and mouth/genital ulcers, and their family members. Researchers want to learn how this condition changes over time, so they can better understand and treat it.
Bethesda, MarylandAges 1 day–99 years - NCT01168271Recruiting
Study malaria risk factors in pregnancy and young children
This study looks at why some people get malaria during pregnancy, and how young children’s bodies respond early in life. It may help researchers understand who is more likely to get malaria and why, which could guide future prevention and care.
BamakoAges 1 day–45 years - NCT05347238Recruiting
Dopamine or norepinephrine for low blood pressure in very preterm babies
This trial compares two common medicines—dopamine versus norepinephrine—to treat low blood pressure in very preterm babies who have suspected or confirmed late-onset bloodstream infection (sepsis). It may help doctors find which medicine works better and more safely for this specific situation.
Phoenix, ArizonaAges 5 months–7 months - NCT06872307Recruiting
Staying on PrEP: a support program for men
This study tests a support program to help people stick with PrEP, a daily pill that prevents HIV. If you've stopped taking PrEP or are thinking about restarting, this program may help you stay protected.
Atlanta, GeorgiaAges 18 years+ - NCT06627764Recruiting
Family support program for Latino families with teens
This study tests a family-based program to help Latino families with teenagers aged 12-17. The program addresses overlapping health and social challenges to improve family well-being.
Durham, North CarolinaAges 12–100 - NCT07444580RecruitingPhase 1
Gene-silencing drug for prion disease
This study tests a new drug that targets the genetic material causing prion disease, aiming to slow or stop the disease. It's for people with symptoms or those at high genetic risk, and involves regular check-ups and spinal taps.
Boston, MassachusettsAges 18 years+ - NCT03712722Recruiting
Stool transplant for clostridium difficile infection
This study tests a treatment called fecal microbiota transplantation (FMT), which puts healthy donor stool into your gut to help fight the bacteria that cause clostridium difficile infection. It may help clear the infection and restore your gut's natural balance.
Aarhus NAges 18–99 - NCT07318584RecruitingPhase 2
Cefotetan for E. coli bloodstream infections
This study tests whether a simpler antibiotic, cefotetan, works as well as the usual treatment for E. coli bloodstream infections. It may offer an effective option with fewer side effects for some patients.
Portland, OregonAges 18 years+ - NCT07227779RecruitingPhase 2
B-PaLMZ for TB meningitis in people with HIV
This trial tests a combination of TB medicines (B-PaLMZ) for people with HIV who have their first episode of TB meningitis. It aims to find a better treatment option.
KampalaAges 18 years+ - NCT07133997RecruitingPhase 1
Combination therapy for relapsed CD19+ B-cell leukemia
This trial tests a new combination of three drugs for patients with relapsed or treatment-resistant CD19-positive B-cell acute lymphoblastic leukemia. It aims to see if adding the drugs venetoclax and asparaginase to blinatumomab can improve outcomes.
Duarte, CaliforniaAges 12–55 - NCT07775313Enrolling by invitationPhase 1/Phase 2
Gene therapy for WHIM syndrome
This trial tests a one-time gene therapy treatment for WHIM syndrome, a rare immune disorder. It aims to fix the genetic cause to improve your body's ability to fight infections. Your stem cells will be collected, edited in a lab, and given back to you after some chemotherapy to prepare your body.
Bethesda, MarylandAges 3–75 - NCT07877662Enrolling by invitation
Partnering VA centers with infectious disease experts
This study helps VA medical centers that don't have their own infectious disease expert get support from a specialist at another VA. It aims to improve how these centers handle infections and quality of care.
Hines, IllinoisAges Any age - NCT07215858RecruitingPhase 2
Testing a new flu vaccine against H1N1 flu
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
Bethesda, MarylandAges 18–55 - NCT06479837Recruiting
Study using tonsil tissue to understand infections
This study uses tonsil tissue that is removed during a routine tonsillectomy to grow tiny 'organoids' in the lab. Researchers will study how germs interact with human cells, which could lead to better treatments for infections.
Bethesda, MarylandAges 2–120 - NCT07306247Recruiting
Light therapy for low-grade cervical changes with HPV 16 or 18
This study tests a light-based treatment called ALA-PDT to see if it can help clear precancerous cervical changes caused by HPV types 16 or 18. It may be an option to avoid more invasive procedures.
Hangzhou, ZhejiangAges 20–60 - NCT06746350Recruiting
Heat therapy for skin sores from leishmaniasis
This study tests if using heat therapy (thermotherapy) in local clinics is a good way to treat skin sores caused by leishmaniasis. It may be an option for people with a few small sores not on the face or near sensitive areas.
Addis AbabaAges 12–60 - NCT07855276RecruitingPhase 1
Study of remibrutinib for moderate to severe hidradenitis suppurativa
This study tests a new oral medication, remibrutinib, in adults with moderate to severe hidradenitis suppurativa (HS), a skin condition causing painful lumps and tunnels. The goal is to see how the drug affects the skin tissue and to gather information for future treatments.
Mayfield Heights, OhioAges 18–65 - NCT07222670RecruitingPhase 2
Nasal spray to prevent respiratory infections in healthy adults
This trial tests a nasal spray, INNA-051, that may help your nose and airways fight off viruses that cause respiratory infections like colds and flu. It is for healthy adults aged 18-45 who are around many people and may be exposed to germs.
Baltimore, MarylandAges 18–45 - NCT06114888Recruiting
New diagnostic tests for children hospitalized with pneumonia
This study tests new ways to diagnose pneumonia in children who are hospitalized. It aims to find the best methods to quickly identify the cause of pneumonia, so your child can get the right treatment sooner.
Hamilton, OntarioAges 6 months–18 years - NCT07093580RecruitingPhase 1
Study of a long-acting injectable in healthy adults
This study tests a new long-acting injectable medication (S-892216 LAI) in healthy adults. It helps researchers understand how the drug works in the body when given as a shot, which could lead to a treatment given less often in the future.
Cypress, CaliforniaAges 18–55 - NCT07225569RecruitingPhase 2
Study of a new drug for moderate to severe hidradenitis suppurativa
This trial tests a new medication, SAR445399, for people with moderate to severe hidradenitis suppurativa (HS) who haven't improved with oral antibiotics. It aims to see if the drug safely reduces skin bumps and abscesses.
Scottsdale, ArizonaAges 18 years+ - NCT07610395RecruitingPhase 2
Testing an oral drug for cold virus in COPD patients
This trial tests an oral medication (VPV) to see if it can safely treat rhinovirus (a common cold virus) in people with COPD. The goal is to help you recover faster and prevent serious COPD flare-ups.
Mobile, AlabamaAges 40–85 - NCT07438041Recruiting
Helping young people start prep for hiv prevention
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
San Francisco, CaliforniaAges 13–24 - NCT07126574Enrolling by invitation
Blood tests for diagnosing sepsis in adult burn patients
This study is testing how well certain blood tests can detect sepsis (a severe infection in the blood) in adults with burns. If you are in the burn ICU with a significant burn and your doctors suspect sepsis, your blood test results may help guide treatment.
SeoulAges 18 years+
Common questions
- How many infections clinical trials are recruiting?
- Clin2 is tracking 3,968 recruiting infectious disease studies from the U.S. registry right now, out of 6,521 we cover in this area in total.
- What does “Infections” cover here?
- Bacterial, viral, and other infections — from common illnesses to emerging threats. We group each study into infections based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a infections trial near me?
- Use the search to filter infections studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.